Quote:
|
However, the government suggested such a change would have limited impact on the biotechnology industry because man-made manipulations of DNA, like methods to create genetically modified crops or gene therapies, could still be patented.
|
I read this to mean a company can patent a therapy for a particular gene, but can't prevent another company from developing a different therapy (which they can patent) for the same gene.
If so, this is very good news, but I doubt this is the end of it. This will most likely go to the supremes.